GSK Investigational Site

RibeirAo PretoSP 14051-140

0 studies enrolling now · 5 studies all time

What they study most

HIV Infections, Respiratory Syncytial Virus Infections

Studies at this site

• Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients — Running, not enrolling
• A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control — Completed
• Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019 — Completed
• A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers — Stopped early
• A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers — Stopped early